The Award Ceiling for Year 1 is 0 (none).
CDC anticipates an Approximate Total Fiscal Year Funding amount of $300,000 for Year 1, subject to the availability of funds.
Angola has persistent public health and social HIV-related challenges.
Findings from the three most recent population-based
HIV sero-surveillance studies, the Demographic and Health Survey (DHS), Integrated Bio-behavioral Surveillance Survey (IBBS), and Seroprevalence and Behavioral Epidemiological Risk Survey (SABERS) confirm that the HIV/AIDS epidemic in Angola is generalized and primarily heterosexually-driven (DHS+ in 2016, IBBS in 2016, SABERS in 2015).
DHS reported an overall HIV prevalence of 2. 0% among adults aged 15-49 years in Angola.
Prevalence among adult females aged 15-49 years is higher than among adult males ( 2. 6% vs.
1. 2%).
HIV prevalence is not evenly distributed throughout the country; it is 1. 9% in Luanda and is equal to or exceeds 4% in Cunene ( 6. 1%), Cuando Cubango ( 5. 5%), and Moxico ( 4. 0%) provinces.
Strategic activities will produce more accurate program data, thereby enabling an increased understanding of the epidemic in Angola, improving the quality of HIV care and treatment services, contributing to HIV epidemic control.
This NOFO will support the continuation and enhancement of INLS's work to strengthen the HIV program across the national and provincial level through providing oversight of HIV related services, which include but are not limited to health systems strengthening, strategic information (SI), HIV Counseling and Testing, Prevention of Mother to Child Transmission (PMTCT), laboratory and other opportunistic infection related services.
Related ProgramsGlobal AIDS
Department of Health and Human Services